全球阿司匹林市场 – 行业趋势和 2030 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球阿司匹林市场 – 行业趋势和 2030 年预测

  • Pharmaceutical
  • Upcoming Report
  • Jun 2023
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Global Aspirin Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2023 –2030
Diagram Market Size (Base Year)
USD MILLION
Diagram Market Size (Forecast Year)
USD MILLION
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

>全球阿司匹林市场,按给药途径(口服、直肠、肠外)、剂型(片剂、胶囊、注射剂、栓剂)、用途(疼痛、发烧和炎症、深静脉血栓形成等)、剂量类型(成人剂量和儿童剂量)、可用性(处方药和非处方药)、产品类型(单独产品和组合产品)、最终用户(医院、诊所、其他)、分销渠道(医院药房、网上药房和零售药房)划分 - 行业趋势和预测到 2030 年。

阿司匹林市场

阿司匹林市场分析和规模

阿司匹林可用于预防各种其他疾病,如癌症、糖尿病、隐球菌感染和神经系统疾病,因为该药物对 COX 依赖和不依赖的机制有影响。医疗保健提供者面临的问题是应该向哪个年龄组推荐阿司匹林,或者应该将其用于心脏病发作和中风的一级预防。阿司匹林使用方面的进展,如 Cardinal Health 已配制出一种水凝胶,其中阿司匹林被用作添加剂。新配方中也使用阿司匹林作为成分,可以增加阿司匹林的市场增长。                             

Data Bridge Market Research 分析称,预测期内阿司匹林市场预计将经历 3.10% 的复合年增长率。由于人口中心脏病的增加,“口服”在阿司匹林市场的给药途径部分占主导地位。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察外,Data Bridge Market Research 整理的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。

阿司匹林市场范围和细分

报告指标

细节

预测期

2023 至 2030 年

基准年

2022

历史岁月

2021 (可定制为 2015-2021)

定量单位

收入(百万美元)、销量(单位)、定价(美元)

涵盖的领域

按给药途径(口服、直肠、肠外)、剂型(片剂、胶囊、注射剂、栓剂)、用途(疼痛、发热和炎症、深静脉血栓形成等)、剂量类型(成人剂量和儿童剂量)、可用性(处方药和非处方药)、产品类型(单独和组合产品)、最终用户(医院、诊所、其他)、分销渠道(医院药房、网上药房和零售药房)

覆盖国家

美国、加拿大、墨西哥、巴西、阿根廷、秘鲁、南美洲其他地区、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、匈牙利、立陶宛、奥地利、爱尔兰、挪威、波兰、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、越南、亚太其他地区、沙特阿拉伯、阿联酋、埃及、以色列、科威特、南非、中东和非洲其他地区

Market Players Covered

  • Bayer AG (Germany), Globalimporter Inc. (China), Allegiant Health (U.S.), Par Pharmaceutical (U.S.), Anastacio Chemistry (Brazil), Cardinal Health (U.S.), Nanjing pharmatechs  Co, ltd. (China), JQC (Huayin) Pharmaceutical Co., Ltd. (China), LNK International, Inc. (U.S.), Globela Pharma Pvt Ltd (India), Bal Pharma Limited (India), Trumac Healthcare (India), Perrigo Company plc (Ireland), Alta Laboratories Ltd (India), Zhenjiang Gaopeng Pharmaceutical CO,.Ltd (China), Seqens (France), Umang Pharmatech Pvt. Ltd. (India), J.M. Loveridge Ltd (U.K.), Mayne Pharma Group Limited (Australia), St. Joseph's Aspirin (U.S.)

Market Opportunities

  • Increasing R&D activities
  • Rising demand in developing countries
  • Increasing strategic collaborations and partnerships

Market Definition

Aspirin also known as acetylsalicylic acid which is mostly use as antipyretic,analgesic and anti-coagulant and is clinically used by the population over 100 years. It is also used in the prevention of cardiovascular disease. It is a cyclooxygenase (COX-1) inhibitor and can modify the enzymatic activity of cyclooxygenase-2 (COX-2). It irreversibly binds with this enzyme and also blocks the thromboxane A2 on platelet therefore, preventing the platelet aggregation.

Aspirin Market Dynamics

Drivers

  • Increasing prevalence of cardiovascular diseases

Heart attacks and strokes are two common cardiovascular disorders that aspirin is frequently used to treat and prevent. Aspirin is becoming more and more popular as a therapy option and a preventive measure as these disorders become more prevalent globally. Thus increase in the incidence rates of cardiac diseases is acting as driver for the market growth.

  • Technological advancements in drug delivery systems

The creation of aspirin formulations with a variable release time has been made possible by technological developments in drug delivery systems. These aspirin formulations offer controlled aspirin release, enabling once-daily dosing and possibly minimising gastrointestinal adverse effects. These developments improve patient adherence and support the expansion of the aspirin market.

  • Rising geriatric population

As the global population ages, age-related illnesses including cardiovascular disease and arthritis are becoming more common. Since aspirin is frequently used to treat these problems. Henceforth, growing ageing population across the globe demonstrates the future growth of the market.

Opportunities

  • Increasing R&D activities

Aspirin is being used in innovative ways that go beyond its conventional uses thanks to ongoing research and clinical trials. Aspirin's potential for preventing cancer, especially colorectal cancer, and its function in reducing the risk of preeclampsia in expectant women are receiving more attention. These potential uses can create new aspirin market niches and possibilities if they are further validated.

  • Increasing strategic collaborations and partnership

Innovation, research acceleration, and market penetration can all be improved by partnerships between pharmaceutical corporations, academic institutions, and healthcare organisations. Partnerships open up chances for market expansion by promoting the creation of novel formulations, combination medicines, and a wider geographic reach.

Restrains/ Challenges

  • Availability of alternative therapies

The demand for aspirin may be affected by the availability of complementary medicines, such as other nonsteroidal anti-inflammatory medications (NSAIDs) and pain management choices. In order to prevent the aspirin market from expanding too much, patients and medical professionals may decide to use other drugs or therapies based on their efficacy, safety profile, patient preferences, and cost-effectiveness.

  • Safety concerns and adverse effects

Although aspirin is typically well accepted, it can have unwanted consequences such gastrointestinal bleeding, ulcers, and a higher risk of bleeding. Some people may choose not to use aspirin or limit its long-term use due to these safety worries and side effects related to its use. Both people and medical professionals may be influenced by the possible dangers and side effects while making decisions.  Thus, safety concerns and adverse effects may hamper the market growth.

  • Strict regulatory framework

Like all medications, aspirin is subject to tight regulatory standards and limitations on labelling. For consumers, these regulations guarantee safety, efficacy, and accurate information. However, aspirin producers may experience operational and financial difficulties as a result of complying with constantly changing laws and label changes. Thus it is predicted that strict regulations is the major key challenge for the future growth of the market.

This aspirin market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the biomarkers market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

  • Bayer announced in December 2021, that it will deploy €100 million to enable more sustainable research, manufacture, and utilization of its Consumer Health supplements, which include global names including Aspirin, Bepanthen, Claritin, and Elevit.

Global Aspirin Market Scope

阿司匹林市场根据给药途径、剂型、应用、剂量类型、可用性、产品类型、最终用户和分销渠道进行细分。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略,并确定您的核心应用领域和目标市场的差异。

给药途径

  • 口服
  • 直肠
  • 肠外

剂型

  • 平板电脑
  • 泡腾片
  • 咀嚼片
  • 薄膜包衣
  • 延长发行
  • 延期发布
  • 肠溶片
  • 胶囊
  • 延长发行
  • 注射
  • 静脉注射
  • 栓剂

应用

  • 疼痛
  • 发烧和炎症
  • 深静脉血栓形成
  • 其他的

剂量类型

  • 成人剂量
  • 儿童剂量

可用性

  • 处方
  • 场外交易

产品类型

  • 独自的
  • 组合产品

最终用户

  • 医院
  • 诊所
  • 其他的

分销渠道

  • 医院药房
  • 网上药店
  • 零售药店

阿司匹林市场区域分析/见解

对全球阿司匹林市场进行了分析,并按国家、给药途径、剂型、应用、剂量类型、可用性、最终用户和分销渠道提供了市场规模信息,如上所述。

阿司匹林市场报告涉及的国家包括北美洲的美国、加拿大、墨西哥、巴西、阿根廷、秘鲁、南美洲其他地区(南美洲的一部分)、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、匈牙利、立陶宛、奥地利、爱尔兰、挪威、波兰、欧洲其他地区(欧洲的一部分)、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、越南、亚太其他地区、沙特阿拉伯、阿联酋、埃及、以色列、科威特、南非、中东和非洲其他地区(中东和非洲的一部分)。

由于成本低廉和政府支持力度加大,亚太地区有望主导市场。由于偏头痛病例数增加,欧洲市场有望增长。

报告的国家部分还提供了影响单个市场因素和国内市场法规变化,这些变化影响了市场的当前和未来趋势。新销售、替代销售、国家人口统计、疾病流行病学和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外,在对国家数据进行预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、销售渠道的影响。   

医疗保健基础设施增长安装基础和新技术渗透

阿司匹林市场还为您提供每个国家/地区资本设备医疗支出增长、阿司匹林市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对阿司匹林市场的影响的详细市场分析。数据涵盖 2010-2021 年的历史时期。

竞争格局和阿司匹林市场份额分析

阿司匹林市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、公司优势和劣势、产品发布、临床试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对阿司匹林市场的关注有关。

阿司匹林市场的一些主要参与者包括:

  • 拜耳公司(德国)
  • Globalimporter Inc. (中国)
  • Allegiant Health(美国)
  • Par Pharmaceutical(美国)
  • Anastacio Chemistry(巴西)
  • 康德乐 (美国)
  • 南京法玛泰克生物技术有限公司 (中国)
  • 金泉城(华阴)药业有限公司 (中国)
  • LNK International, Inc.(美国)
  • Globela Pharma Pvt Ltd(印度)
  • Bal Pharma Limited(印度)
  • Trumac Healthcare(印度)
  • Perrigo Company plc(爱尔兰)
  • Alta Laboratories Ltd(印度)
  • 镇江高鹏药业有限公司 (中国)
  • Seqens(法国)
  • Umang Pharmatech Pvt. Ltd.(印度)
  • JM Loveridge Ltd(英国)
  • Mayne Pharma Group Limited(澳大利亚)
  • 圣约瑟夫阿司匹林(美国)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Aspirin Market is expected to grow at a CAGR of 3.10% by 2030
The major companies of Aspirin Market in the aspirin market are Bayer AG, Globalimporter Inc., Allegiant Health, Par Pharmaceutical, Anastacio Chemistry, Cardinal Health, Nanjing pharmatechs Co, ltd., JQC (Huayin) Pharmaceutical Co., Ltd., LNK International, Inc., Globela Pharma Pvt Ltd , Bal Pharma Limited, Trumac Healthcare, Perrigo Company plc, Alta Laboratories Ltd, Zhenjiang Gaopeng Pharmaceutical CO, Ltd, Seqens, Umang Pharmatech Pvt. Ltd., J.M. Loveridge Ltd, Mayne Pharma Group Limited, St. Joseph's Aspirin.
The Increasing prevalence of cardiovascular diseases, Technological advancements in drug delivery systems, and Rising geriatric population are the Growth Drivers of the Aspirin Market
The route of administration, dosage form, applications, dose type, availability, product type, end-user and distribution channel are the factors on which the Aspirin Market research is based.
Bayer announced that it will deploy €100 million to enable more sustainable research, manufacture, and utilization of its Consumer Health supplements, which include global names including Aspirin, Bepanthen, Claritin, and Elevit are the latest developments in the Aspirin Market.